Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports

Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant tre...

Celý popis

Podrobná bibliografia

Vydané v:	Journal of international medical research Ročník 44; číslo 1_suppl; s. 67 - 71
Hlavní autori:	De Simone, Clara, Perino, Francesca, Caldarola, Giacomo, D’Agostino, Magda, Peris, Ketty
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London, England SAGE Publications 01.09.2016
Predmet:	Immuno-Mediated Diseases And Comorbities Antitumour necrosis factor-α agents psoriatic arthritis comorbidities etanercept psoriasis
ISSN:	0300-0605, 1473-2300, 1473-2300
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!